Search:
Eligible? Enter your email with the company domain to determine your eligibility.

Am I Eligible?

By entering your location and email address, we can determine if your company is eligible to participate in the BIO Business Solutions® cost - savings programs. If your company is eligible you will be directed to a page outlining the benefits available to you.

Not in the US? View programs available in:
Canada Puerto Rico United Kingdom
United States

Learn more about Illumina

Take advantage of these member benefits.

Request More Information

Contact

Erika Ramko
858-882-2527
eramko@illumina.com

www.illumina.com

Enrollment & Use of Program
I already use one of the BIO’s preferred suppliers. Will I have to change the way I do business with that provider? Will I have a limited selection?
Not at all....
Eligibility
Who is eligible to join the program?
The BIO Business Solutions® program is open to all member c...

Have a question about BIO Business Solutions? Submit it here >

See all Frequently Asked Questions
“The benefits are huge. As a CFO, I’m always looking to save money. Everybody wants to save money. This program provides a unique opportunity to do that – for my company that’s hundreds of thousands of dollars.”
William Waddill
CFO, Oncomed Pharmaceuticals
“Now I have hands that are devoted to something else rather than working on deals that the BIO Business Solutions group has already done for us.”
Isaac Young
Senior Director, Supply Chain Operations, BioMarin Pharmaceutical Inc.
See all Testimonials

Illumina

Gene Sequencing Solutions

Illumina, A global genomics leader, provides comprehensive next-generation sequencing (NGS) solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.1 Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. By empowering large-scale analysis of genetic variation and function, Illumina is enabling studies that were not imaginable just a few years ago, moving us closer to the realization of precision medicine. 
1Data calculations on file. Illumina, Inc., 2015.

Member Benefits

Through this program, Illumina offers exclusive rebates to first-time Illumina customers only on the following benchtop sequencing instrumentation to member companies:

Low-throughput Instruments
MiSeq® Allows small genome sequencing and assembly, and enables detection of targeted variants with unmatched accuracy 
MiSeqDx®* First FDA cleared IVD platform with a growing menu of assays that enables clinical laboratories to create and deploy NGS based molecular diagnostic testing in their labs
MiSeq FGx™ A compact, fully validated NGS platform for forensic genomics applications 
MiniSeq™ Flexible and affordable system that allows researchers to transition easily between sequencing projects for both DNA and RNA 

 *For In Vitro Diagnostic Use Only

Mid-throughput Instruments
NextSeq®500 Enables rapid sequencing of exomes, targeted panels, and transcriptomes
NextSeq®550 Enables NGS and Cytogenetic Array Scanning on one instrument     

For Research Use Only. Not for use in diagnostic procedures. 

Eligible Biotech Associations

In addition to members of BIO, members of the following state and regional biotech associations can take advantage of this program:

Alabama

Arizona

California

Colorado

Connecticut

Delaware

Florida

Georgia

Idaho

Illinois

Indiana

Kansas

Kentucky

Louisiana

Maine

Maryland

Michigan

Missouri

Montana

Nevada

New Jersey

New Mexico

New York

North Carolina

North Dakota

Ohio

Oregon

Rhode Island

South Carolina

Tennessee

Texas

Utah

Virginia

Washington